Health-related quality of life in economic evaluations for osteoporosis: whose values should we use?
about
Parents' reported preference scores for childhood atopic dermatitis disease statesAre decisions using cost-utility analyses robust to choice of SF-36/SF-12 preference-based algorithm?Estimating utility weights and quality-adjusted life year loss for colorectal cancer-related health states in KoreaHealth-related quality of life changes associated with buprenorphine treatment for opioid dependence.An off-the-shelf help list: a comprehensive catalog of preference scores from published cost-utility analyses.Measuring preferences for cost-utility analysis: how choice of method may influence decision-makingComparing the incomparable? A systematic review of competing techniques for converting descriptive measures of health status into QALY-weights.Do visual analogue scale (VAS) derived standard gamble (SG) utilities agree with Health Utilities Index utilities? A comparison of patient and community preferences for health status in rheumatoid arthritis patients.Eliciting women's preferences in health care: a review of the literature.A review and meta-analysis of prostate cancer utilities.Cognitive impairment and preferences for current health.How bad is depression? Preference score estimates from depressed patients and the general population.Comparison of EQ-5D, HUI, and SF-36-derived societal health state values among spine patient outcomes research trial (SPORT) participantsA review and meta-analysis of utility values for lung cancer.Health-state utility values in breast cancer.Pharmacoeconomics of bisphosphonates for skeletal-related event prevention in metastatic non-breast solid tumours.A systematic review and meta-analysis of utility-based quality of life for osteoporosis-related conditions.Sourcing quality-of-life weights obtained from previous studies: theory and reality in Korea.Cost effectiveness of raloxifene in the treatment of osteoporosis in Sweden: an economic evaluation based on the MORE study.Cost-effectiveness and economic impact of the KineSpring ® Knee Implant System in the treatment for knee osteoarthritis.A meta-analysis of utility estimates for HIV/AIDS.Quality of life after hip, vertebral, and distal forearm fragility fractures measured using the EQ-5D-3L, EQ-VAS, and time-trade-off: results from the ICUROS.Comparison of directly elicited preferences to preferences derived from the SF-36 in adults with asthma.The International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)--quality of life during the first 4 months after fracture.Willingness to pay in arthritis: a Danish contribution.The practicality and validity of directly elicited and SF-36 derived health state preferences in patients with low back pain.A comparison of HUI2 and HUI3 utility scores in Alzheimer's disease.Comparison of Health State Utilities Using Community and Patient Preference Weights Derived from a Survey of Patients with HIV/AIDS
P2860
Q24795485-F6B5188E-0AA9-46E3-B9F1-3352F6E42230Q24805172-D7667618-07A3-4451-B798-994D534C6D18Q33912097-1E6D4C9C-FDAA-4063-A572-3A3BCC76EABDQ34129263-852C07FA-8643-41B7-A716-958E5830B665Q34320716-66D609B4-D610-434C-8FDA-88E938C4AEB7Q34614168-B2C6A454-9C5A-4DA8-B2DC-F946B61AF5E2Q34748545-C1BC7C64-454D-400A-8613-AA86FC6B5F0BQ35005535-43FB723D-EE0F-46E5-9D52-DFE00C45A4B4Q35812283-6858B12A-A9AF-4C19-B9BD-E9B855502596Q36821787-EC89E898-48B4-4756-9F08-AC832326661FQ37078424-7A064845-8603-466D-8066-660D0388A80DQ37335748-3A32D508-18FD-4984-8E8D-8BD2C39EA726Q37435131-F78E19FB-83E8-412D-A7C1-4BFA75F3CFC2Q37744304-7EC0B2BC-4DAC-4CF6-8E87-8016D6083C5FQ37800481-6B6DE890-8D50-437A-B6F2-C4A49E513025Q38002500-8C4DFBCE-D117-4F27-9BA1-3B2023F3C0F5Q38190449-73930100-27A7-49B5-A49A-11DB8CD8C82EQ38191873-2F7A34D4-8459-4854-87F7-D1B7B0CBC59AQ45196993-351D4C98-AD32-4773-9066-9A3BE6FA9F75Q45829154-87E846BC-9091-4EEC-BAD1-D98268F02D42Q46061609-B4C4B83C-EF04-49C1-ADE0-B944B22F2F72Q46217023-976B8FCB-36C6-42DC-BC7D-2C4F95D5CCDFQ47680409-1FDFEDBC-38AF-462F-B38B-F495A7303E70Q48319752-B5C1767C-A08F-4F29-A016-56D6A03C9CF6Q50567309-471C0071-F0B3-47B4-BB8C-E70792BB2E62Q52048603-87AF5582-3320-4371-B3AE-8B8362B5B354Q53238664-7C245693-F51C-476E-ADC8-5996286991CAQ59152682-7C15AA7C-2FE7-4B86-913C-C69F7BAA7045
P2860
Health-related quality of life in economic evaluations for osteoporosis: whose values should we use?
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Health-related quality of life ...... s: whose values should we use?
@ast
Health-related quality of life ...... s: whose values should we use?
@en
type
label
Health-related quality of life ...... s: whose values should we use?
@ast
Health-related quality of life ...... s: whose values should we use?
@en
prefLabel
Health-related quality of life ...... s: whose values should we use?
@ast
Health-related quality of life ...... s: whose values should we use?
@en
P2093
P2860
P1476
Health-related quality of life ...... s: whose values should we use?
@en
P2093
A N Tosteson
B Ettinger
L J Melton
M M Moncur
S E Gabriel
T S Kneeland
P2860
P304
P356
10.1177/0272989X9901900204
P577
1999-04-01T00:00:00Z